- Home
- OWL vs FMS Comparison
OWL vs FMS Comparison
Compare OWL & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OWL
- FMS
- Stock Information
- Founded
- OWL 2020
- FMS 1996
- Country
- OWL United States
- FMS Germany
- Employees
- OWL N/A
- FMS N/A
- Industry
- OWL Investment Managers
- FMS Misc Health and Biotechnology Services
- Sector
- OWL Finance
- FMS Health Care
- Exchange
- OWL Nasdaq
- FMS Nasdaq
- Market Cap
- OWL 12.5B
- FMS 13.8B
- IPO Year
- OWL N/A
- FMS 1996
- Fundamental
- Price
- OWL $18.69
- FMS $28.39
- Analyst Decision
- OWL Buy
- FMS Hold
- Analyst Count
- OWL 15
- FMS 1
- Target Price
- OWL $24.10
- FMS $30.00
- AVG Volume (30 Days)
- OWL 7.0M
- FMS 625.1K
- Earning Date
- OWL 05-01-2025
- FMS 05-06-2025
- Dividend Yield
- OWL 4.82%
- FMS 2.77%
- EPS Growth
- OWL 23.81
- FMS 27.83
- EPS
- OWL 0.16
- FMS 2.28
- Revenue
- OWL $2,465,573,000.00
- FMS $21,068,786,202.00
- Revenue This Year
- OWL $20.11
- FMS $2.74
- Revenue Next Year
- OWL $21.44
- FMS $3.60
- P/E Ratio
- OWL $118.57
- FMS $24.92
- Revenue Growth
- OWL 32.99
- FMS 0.10
- 52 Week Low
- OWL $14.55
- FMS $17.93
- 52 Week High
- OWL $26.73
- FMS $30.46
- Technical
- Relative Strength Index (RSI)
- OWL 49.57
- FMS 56.82
- Support Level
- OWL $17.74
- FMS $28.45
- Resistance Level
- OWL $19.05
- FMS $29.71
- Average True Range (ATR)
- OWL 0.52
- FMS 0.40
- MACD
- OWL -0.03
- FMS -0.15
- Stochastic Oscillator
- OWL 37.50
- FMS 22.28
About OWL Blue Owl Capital Inc.
Blue Owl Capital Inc is an alternative asset management firm. The company deploys private capital across Credit, GP Strategic Capital, and Real Estate platforms on behalf of institutional and private wealth clients. The company conducts its operations through Blue Owl Capital Holdings LP (Blue Owl Holdings) and Blue Owl Capital Carry LP (Blue Owl Carry). Its investor base includes a diversified mix of institutional investors, including public and private pension funds, endowments, foundations, family offices, private banks, high-net-worth individuals, asset managers, and insurance companies. The company generates substantially all of its revenues in the United States.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three quarters of sales while the balance is generated from medical technology products that enable dialysis treatments.